Factors controlling cytoplasmic Ca 2+  concentration.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D002127:Calcium Isotopes; D002463:Cell Membrane Permeability; D003593:Cytoplasm / Q000378:metabolism; D004140:Dinitrophenols / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007461:Iodoacetates / Q000494:pharmacology; D007700:Kinetics; D007811:Lanthanum / Q000494:pharmacology; D008094:Lithium / Q000494:pharmacology; D009130:Muscle, Smooth / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits; D012964:Sodium / Q000494:pharmacology
D002127:Calcium Isotopes; D004140:Dinitrophenols; D007461:Iodoacetates; D009467:Neuromuscular Depolarizing Agents; D000804:Angiotensin II; D010042:Ouabain; D007811:Lanthanum; D000255:Adenosine Triphosphate; D008094:Lithium; D012964:Sodium; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine